 Diabetic Care Device is an extensive classification of different products amalgamated to monitor and control the blood glucose levels in the human body. The Diabetic Care devices market in the US has transformed from niche to mainstream, owing to the increasing number of diabetic patients and growing ageing population in the country. Diabetic equipments have slowly become an integral part of present day’s fast paced lifestyles along with other changes such as increasing acceptability and affordability of these products. SMBG is a fundamental component of intensive diabetes management and has been the standard of care for many years in the past. The US is estimated to be the largest SMBG devices market across the globe which has grown at a CAGR of 5.3% during the period of 2007-2013. The US SMBG devices market is dominated by the glucose test strips segment. A combination of technology innovation, patient education and economic incentives are likely to significantly expand the SMBG market in the country and build sustainable long term dollar growth for SMBG vendors. Continuous Glucose Monitoring System is a highly useful device as it provides greater insight into blood glucose levels all day by instilling a small sensor under the skin. This ground-breaking technology offers frequent information on blood sugar levels and the effect of diet, exercise and insulin on blood sugar. The market for CGM devices will also grow in light of rising demand for more accurate and more patient friendly diabetic care devices. Insulin delivery devices are majorly constituted by Insulin Syringe, Insulin pen and Insulin Pump. The market for diabetic care has been dominated by insulin pens occupying more than half of the insulin delivery devices market in the US. This category of insulin delivery devices has been significantly dominated by the middle aged population falling in the age group of 40-59 years. Insulin pens offer potential benefits of lifestyle flexibility and enriched glycemic control. The US market for Insulin Pumps grew by an average annual growth rate of 14%. The insulin syringe market is dominated by Becton and B Braun which together command the insulin syringe market. “The baby boom generation is becoming aged while the aged population is accompanied by costly chronic diseases. In light of this, policymakers are developing policies that will help curb the expected rise in diabetes burden and eventually contribute to the growth of diabetic devices in the country” - according to the Research Associate, Ken Research. The report titled “The US Diabetic Devices Industry Outlook to 2018- Growth to be Led by Next Generation Technology” provides detailed overview on the US Diabetic Devices Market and helps readers to identify the ongoing trends in the industry and anticipated growth in future depending upon changing industry dynamics in coming years. The report will help industry consultants and diabetic devices companies to align their market centric strategies according to ongoing and expected trends in the future. Read More: http://www.kenresearch.com/healthcare/medical-devices-and-equipments/us-diabetic-device-market-research-report/468-91.html Contact Person: Ankur Gupta
E-mail: ankur@kenresearch.com
Related Articles -
SMBG Devices, CGM Systems and Insulin Delivery Devices, Blood Glucose Meters, Blood Glucose Test Strips and Lancets and Lancing Devices, Insulin Pum,
| 
